Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Jul 1;22(13):1731-6.
doi: 10.1101/gad.1695808.

POT of gold: modeling dyskeratosis congenita in the mouse

Chantal Autexier  1
Affiliations
Comment

POT of gold: modeling dyskeratosis congenita in the mouse

Chantal Autexier. Genes Dev. .

Abstract

Dyskeratosis congenita (DC) is a rare syndrome, characterized by cutaneous abnormalities and premature death caused by bone marrow failure. In this issue of Genes & Development, Hockemeyer and colleagues (pp. 1773-1785) report a new mouse model that reconstitutes key features of DC. Disease phenotypes are generated by a POT1b deletion in a telomerase-deficient background that accelerates the shortening of telomeres by degradation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Telomere-shortening mouse models. (Top left panel) Telomerase deficiency (mTR−/− in a C57BL/6J genetic background with long telomeres) leads to progressive shortening. Telomerase deficiency (mTR−/− in a CAST/EiJ genetic background with short telomeres) also leads to progressive telomere shortening, though the final telomere lengths are shorter (cf. top panels). A POT1b deletion leads to accelerated telomere shortening due to excessive 5′ C-strand degradation. (Bottom left panel) Excessive C-strand degradation results in longer G-tails. (Bottom right panel) Telomeres are further shortened in the context of mTR heterozygosity.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Armanios M., Chen J.-L., Chang Y.-P.C., Brodsky R.A., Hawkins A., Griffin C.A., Eshleman J.R., Cohen A.R., Chakravarti A., Hamosh A., et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl. Acad. Sci. 2005;102:15960–15964. - PMC - PubMed
    1. Autexier C., Lue N. The structure and function of telomerase reverse transcriptase. Annu. Rev. Biochem. 2006;75:493–517. - PubMed
    1. Baumann P. Are mouse telomeres going to pot? Cell. 2006;126:33–36. - PubMed
    1. Baumann P., Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 2001;292:1171–1175. - PubMed
    1. Blasco M.A., Lee H.-W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91:25–34. - PubMed

Publication types

LinkOut - more resources